NEW YORK, Sept. 11 – DeCode of Reykjavik, Iceland said Tuesday that it has achieved several milestones in its deal with Roche to identify genes related to obesity and clinical anxiety.

DeCode said in a statement that it used genotypic data from more than 11,000 volunteers to locate a chromosomal region that contributes to obesity. The company said that through its studies it also located a gene variant that may protect obese people from contracting type-2 diabetes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.